Pepaxto

melphalan flufenamide

Approval

ApplicationNDA 214383
Approval dateFeb 26, 2021
Approval year2021
SponsorSponsor not identified

FDA-approved use

To treat relapsed or refractory multiple myeloma

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Pepaxto: